2017: a pivotal year for the MSIF movement

20th December 2017

This year marked the 50th anniversary of the MS International Federation, giving us a valuable opportunity to…

Study shows taking MS medications as directed is better for overall health

14th December 2017

Canadian research reveals the positive effects of taking MS medications as prescribed on a person's general health

New study shows cold water in the mouth can reduce heat sensitivity in MS

14th December 2017

Cold water in the mouth can help reduce heat sensitivity, a common symptom of MS.

Disappointing results from CCSVI treatment trial

13th December 2017

Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that…

Discovering how immune cells get into the brain in MS

13th December 2017

Study reveals important mechanism that allows immune cells to attack myelin in MS

MS Australia publishes first report on MS Specialist Nurses in Australia

24th November 2017

A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s…

Art University redecorates facilities of Brazilian MS Association

22nd November 2017

Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between…

Leading Belgian politician presents 2017 “MS@Work” awards

21st November 2017

Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring…

2017 McDonald Fellowship and Du Pré grant recipients announced

20th November 2017

MSIF is proud to announce the recipients of the 2017 McDonald fellowships and Du Pre grants

Portuguese MS Society (SPEM) launches new Support Line service

20th November 2017

New Support Line will provide information and support, as well as jobs for people living with MS

European Medicines Agency recommends market authorisation for ocrelizumab (Ocrevus) in EU

16th November 2017

The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be…

Using Data to individualise patient treatments

6th November 2017

Scientists have been using a large database to develop algorithms to predict individual responses to a particular…